{"id":"NCT01360632","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of the Safety and Efficacy of Two Fixed Doses of OPDC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Polaris Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06","primaryCompletion":"2013-08","completion":"2013-09","firstPosted":"2011-05-25","resultsPosted":"2016-01-01","lastUpdate":"2016-01-01"},"enrollment":1539,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Depressive Disorder","Depression","Depressive Disorder, Major","Mood Disorders","Mental Disorders"],"interventions":[{"type":"DRUG","name":"OPC-34712 + ADT","otherNames":[]},{"type":"DRUG","name":"Placebo + ADT","otherNames":[]},{"type":"DRUG","name":"Placebo + ADT","otherNames":[]}],"arms":[{"label":"Phase B","type":"EXPERIMENTAL"},{"label":"Phase A","type":"PLACEBO_COMPARATOR"}],"summary":"To compare the effect of OPC-34712 (brexpiprazole) to the effect of placebo (an inactive substance) as add on treatment to an assigned FDA approved antidepressant treatment (ADT) in patients with Major Depressive Disorder who demonstrate an incomplete response to a prospective trial of the same assigned FDA approved ADT","primaryOutcome":{"measure":"Mean Change From the End of Phase A (Week 8 Visit) to Phase B (Week 14 Visit) in the Montgomery-Asberg Depression Rating Scale for the Efficacy Sample Set","timeFrame":"Baseline and Week 14","effectByArm":[{"arm":"Brexpiprazole (1mg) + ADT","deltaMin":-7.65,"sd":0.5},{"arm":"Brexpiprazole (3mg) + ADT","deltaMin":-7.98,"sd":0.51},{"arm":"Placebo + ADT","deltaMin":-6.45,"sd":0.51}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0925"},{"comp":"OG001 vs OG002","p":"0.0327"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":71,"countries":["United States","Canada","Germany","Hungary","Romania","Russia","Ukraine"]},"refs":{"pmids":["40852147","40607746","38421922","37656180","37099968","31577867","30508090","27208498","26301771"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":226},"commonTop":["Headache","Akathisia","Weight increased","Tremor","Nasopharyngitis"]}}